Skip to main content
Premium Trial:

Request an Annual Quote

Nextval Gets Phase II SBIR Grant for Screening System

NEW YORK (GenomeWeb News) – Nextval has received a $500,000 Phase II SBIR grant from the National Science Foundation to support further development and commercialization of its high-throughput screening system that employs mass spectrometry imaging and microarrays.

The Encinitas, Calif.-based firm said the system is a "novel integration of a nanoliter volume acoustic dispense device with chip-based mass spectrometry." It produces high-density arrays that are analyzed with mass spec imaging and computational algorithms to rapidly screen chemical libraries for high-value molecules, the firm said. It also doesn't require sample labeling.

Nextval said its phase II efforts are focused on a screening product for cellulose enzyme discovery, an enzyme used for production of alternative fuels.

The technology also may be applied to discovery of new enzymes and molecules for the industrial, environmental, pharmaceutical, and diagnostic markets, said Nextval.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.